아기오스제약(주)
MX ˙ BMV ˙ US00847X1046
SecurityMX:AGIO / Agios Pharmaceuticals, Inc.
InstitutionCapital Fund Management S.a.
Latest Disclosed Ownership129,531 shares
Latest Disclosed Value $ 4,382,033
Capital Fund Management S.a. ownership in AGIO / Agios Pharmaceuticals, Inc.

On May 14, 2026 - Capital Fund Management S.a. filed a 13F-HR form disclosing ownership of 129,531 shares of Agios Pharmaceuticals, Inc. (MX:AGIO) valued at $4,382,033 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 35,788 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of 261.94% during the quarter.

Capital Fund Management S.a. has a history of taking positions in derivatives of the underlying security (AGIO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:AGIO / Agios Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AGIOS PHARMACEUTICALS INC COM AGIOS PHARMACEUTICALS INC COM 00847X104 129,531 93,743 261.94 4,382 349.90 0.0198
2026-02-17 2025-12-31 13F AGIOS PHARMACEUTICALS INC COM AGIOS PHARMACEUTICALS INC COM 00847X104 35,788 35,788 974 0.0027
2025-11-13 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -68,502 -100.00 0 -100.00
2025-08-13 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 68,502 -3,800 -5.26 2,278 7.55 0.0063
2025-05-14 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 72,302 72,302 2,118 0.0061
2023-11-14 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -41,455 -100.00 0 -100.00
2023-08-14 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 41,455 10,736 34.95 1,174 66.52 0.0048
2023-05-15 2023-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 30,719 -21,597 -41.28 706 -52.01 0.0034
2023-02-13 2022-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 52,316 39,042 294.12 1,469 291.73 0.0099
2022-11-14 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 13,274 13,274 375 0.0029
2021-02-12 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -34,234 -100.00 0 -100.00
2020-11-13 2020-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 34,234 20,293 145.56 1,198 60.81 0.0148
2020-08-13 2020-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 13,941 13,941 746 0.0118
2020-05-13 2020-03-31 13F Agios Pharmaceuticals COM 00847X104 0 -17,705 -100.00 0 -100.00
2020-02-13 2019-12-31 13F Agios Pharmaceuticals COM 00847X104 17,705 1,331 8.13 845 59.13 0.0066
2019-11-13 2019-09-30 13F Agios Pharmaceuticals COM 00847X104 16,374 16,374 531 0.0048
2017-08-10 2017-06-30 13F Agios Pharmaceuticals COM 00847X104 0 -88,185 -100.00 0 -100.00
2017-05-03 2017-03-31 13F Agios Pharmaceuticals COM 00847X104 88,185 88,185 5,150 0.0429
2017-02-08 2016-12-31 13F Agios Pharmaceuticals COM 00847X104 0 -95,510 -100.00 0 -100.00
2016-10-31 2016-09-30 13F Agios Pharmaceuticals COM 00847X104 95,510 65,663 220.00 5,045 303.60 0.0463
2016-07-27 2016-06-30 13F Agios Pharmaceuticals COM 00847X104 29,847 29,847 0.00 1,250 0.0117
2016-05-02 2016-03-31 13F Agios Pharmaceuticals COM 00847X104 0 0 0 0.0000
2016-01-28 2015-12-31 13F Agios Pharmaceuticals COM 00847X104 0 -101,299 -100.00 0 -100.00
2015-10-27 2015-09-30 13F Agios Pharmaceuticals COM 00847X104 101,299 80,888 396.30 7,151 215.30 0.0799
2015-07-28 2015-06-30 13F Agios Pharmaceuticals COM 00847X104 20,411 20,411 2,268 0.0288
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-08-13 2020-06-30 13F Agios Pharmaceuticals COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F Agios Pharmaceuticals COM Call 6,100 216 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-08-13 2020-06-30 13F Agios Pharmaceuticals COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F Agios Pharmaceuticals COM Put 7,300 259 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.